It has been well documented that both protein and mRNA expression levels of TIM-3 are elevated in tumor tissue samples and that elevated TIM-3 is associated with poor prognosis in various tumors, including sarcomas [31, 32]. This evidence concerns the gene HAVCR2 and neoplasm.